标题
Clinical targeting of the TNF and TNFR superfamilies
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 12, Issue 2, Pages 147-168
出版商
Springer Nature
发表日期
2013-01-21
DOI
10.1038/nrd3930
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase I study of CS-1008 (humanized monoclonal antibody targeting death receptor 5 or DR5), administered weekly to patients with advanced solid tumors or lymphomas
- (2017) M. N. Saleh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I trial of LBY135, a monoclonal antibody agonist to DR5, alone and in combination with capecitabine in advanced solid tumors
- (2017) S. Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I study of BMS-663513, a fully human anti-CD137 agonist monoclonal antibody, in patients (pts) with advanced cancer (CA)
- (2017) M. Sznol et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL
- (2014) M. J. Benson et al. JOURNAL OF IMMUNOLOGY
- Glucocorticoid-Induced Tumor Necrosis Factor Receptor Family-Related Protein Exacerbates Collagen-Induced Arthritis by Enhancing the Expansion of Th17 Cells
- (2012) Shengjun Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Long-Term Hepatic Allograft Acceptance Based on CD40 Blockade by ASKP1240 in Nonhuman Primates
- (2012) T. Oura et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
- (2012) H. L. Kindler et al. ANNALS OF ONCOLOGY
- The anti-Fn14 antibody BIIB036 inhibits tumor growth in xenografts and patient derived primary tumor models and enhances efficacy of chemotherapeutic agents in multiple xenograft models
- (2012) Jennifer S. Michaelson et al. CANCER BIOLOGY & THERAPY
- Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity
- (2012) Timothy S. Fisher et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of a Human Monoclonal Antibody for Potential Therapy of CD27-Expressing Lymphoma and Leukemia
- (2012) L. A. Vitale et al. CLINICAL CANCER RESEARCH
- Phase I Study of Atacicept in Relapsed/Refractory Multiple Myeloma (MM) and Waldenström's Macroglobulinemia
- (2012) Jean-François Rossi Clinical Lymphoma Myeloma & Leukemia
- First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: A Phase I/II open-label and double-blind study
- (2012) George D. Demetri et al. EUROPEAN JOURNAL OF CANCER
- Role of TWEAK in lupus nephritis: A bench-to-bedside review
- (2012) Jennifer S. Michaelson et al. JOURNAL OF AUTOIMMUNITY
- Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
- (2012) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases; focus on inflammatory bowel diseases
- (2012) Taeko Dohi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial
- (2012) Mark T. Brown et al. JOURNAL OF PAIN
- Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia
- (2012) John C. Byrd et al. LEUKEMIA & LYMPHOMA
- TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
- (2012) C. T. Hellwig et al. MOLECULAR CANCER THERAPEUTICS
- TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
- (2012) Adam P. Gregory et al. NATURE
- The discovery and development of belimumab: the anti-BLyS–lupus connection
- (2012) William Stohl et al. NATURE BIOTECHNOLOGY
- Anti-NGF painkillers back on track?
- (2012) David Holmes NATURE REVIEWS DRUG DISCOVERY
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- In Vivo Depletion of Lymphotoxin-Alpha Expressing Lymphocytes Inhibits Xenogeneic Graft-versus-Host-Disease
- (2012) Eugene Y. Chiang et al. PLoS One
- Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial
- (2012) Brinda Emu et al. ARTHRITIS RESEARCH & THERAPY
- Serum OX40 ligand levels in asthmatic children: A potential biomarker of severity and persistence
- (2011) Mohamed Hesham Mohamed Ezzat et al. ALLERGY AND ASTHMA PROCEEDINGS
- CD40-Specific Costimulation Blockade Enhances Neonatal Porcine Islet Survival in Nonhuman Primates
- (2011) P. Thompson et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial
- (2011) R. F. van Vollenhoven et al. ARTHRITIS AND RHEUMATISM
- Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice
- (2011) Chaim O. Jacob et al. ARTHRITIS AND RHEUMATISM
- Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer
- (2011) Wan-Wan Lin et al. BIOCHEMICAL PHARMACOLOGY
- Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas
- (2011) M. Guadagnoli et al. BLOOD
- Pharmacological modulation of GITRL/GITR system: therapeutic perspectives
- (2011) Giuseppe Nocentini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
- (2011) Jens Rüter et al. CANCER BIOLOGY & THERAPY
- An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
- (2011) Nicholas S. Wilson et al. CANCER CELL
- Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient
- (2011) An M. T. Van Nuffel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular Pathways: Osteoclast-Dependent and Osteoclast-Independent Roles of the RANKL/RANK/OPG Pathway in Tumorigenesis and Metastasis
- (2011) W. C. Dougall CLINICAL CANCER RESEARCH
- A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies
- (2011) M. A. Fanale et al. CLINICAL CANCER RESEARCH
- The TWEAK-Fn14 System: Breaking the Silence of Cytokine-Induced Skeletal Muscle Wasting
- (2011) S. Bhatnagar et al. CURRENT MOLECULAR MEDICINE
- TNF Superfamily Networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14)
- (2011) Carl F Ware et al. CURRENT OPINION IN IMMUNOLOGY
- Enhancement of anti-tumor immunity through local modulation of CTLA-4 and GITR by dendritic cells
- (2011) Scott K. Pruitt et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Upregulation and nuclear localization of TNF-like Cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions
- (2011) Giorgos Bamias et al. EXPERIMENTAL DERMATOLOGY
- Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults
- (2011) Madhuri Bajaj et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma
- (2011) Xiang-Yang Wang et al. EXPERT OPINION ON PHARMACOTHERAPY
- Interleukin-13 Damages Intestinal Mucosa via TWEAK and Fn14 in Mice—A Pathway Associated With Ulcerative Colitis
- (2011) Rei Kawashima et al. GASTROENTEROLOGY
- OX40 and CD30 signals in CD4+ T-cell effector and memory function: a distinct role for lymphoid tissue inducer cells in maintaining CD4+ T-cell memory but not effector function
- (2011) David R. Withers et al. IMMUNOLOGICAL REVIEWS
- TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
- (2011) Linda C. Burkly et al. IMMUNOLOGICAL REVIEWS
- TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation
- (2011) Françoise Meylan et al. IMMUNOLOGICAL REVIEWS
- The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
- (2011) Marcos W. Steinberg et al. IMMUNOLOGICAL REVIEWS
- T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy
- (2011) Laura M. Snell et al. IMMUNOLOGICAL REVIEWS
- The role of core TNF/LIGHT family members in lymph node homeostasis and remodeling
- (2011) Mingzhao Zhu et al. IMMUNOLOGICAL REVIEWS
- Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
- (2011) Socrates Papapoulos et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer
- (2011) Jean-Charles Soria et al. JOURNAL OF CLINICAL ONCOLOGY
- B Cell Maturation Antigen Deficiency Exacerbates Lymphoproliferation and Autoimmunity in Murine Lupus
- (2011) C. Jiang et al. JOURNAL OF IMMUNOLOGY
- Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice
- (2011) Susan S. Kim et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Development of an Fn14 agonistic antibody as an anti-tumor agent
- (2011) Jennifer S. Michaelson et al. mAbs
- Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
- (2011) Fernando Pastor et al. MOLECULAR THERAPY
- The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling
- (2011) Taylor A Doherty et al. NATURE MEDICINE
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study
- (2011) H. Nagashima et al. OSTEOARTHRITIS AND CARTILAGE
- Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain
- (2011) T.J. Schnitzer et al. OSTEOARTHRITIS AND CARTILAGE
- Efficacy and safety of tanezumab in the treatment of chronic low back pain
- (2011) Nathaniel Katz et al. PAIN
- Blocking the effects of NGF as a route to safe and effective pain relief – fact or fancy?
- (2011) Ray Hill PAIN
- BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
- (2011) Xiaohui Zhou et al. PLoS One
- Therapeutic Targeting of CD95 and the TRAIL Death Receptors
- (2011) Jeannette Gerspach et al. Recent Patents on Anti-Cancer Drug Discovery
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- The Involvement of Epithelial Fas in a Human Model of Graft Versus Host Disease
- (2011) Nicolas Ruffin et al. TRANSPLANTATION
- TNF superfamily in inflammatory disease: translating basic insights
- (2011) Michael Croft et al. TRENDS IN IMMUNOLOGY
- Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an Fc RIIIa-158 V/F polymorphism
- (2010) K. A. Blum et al. ANNALS OF ONCOLOGY
- Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
- (2010) Michael Croft Annual Review of Immunology
- A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma
- (2010) A Younes et al. BRITISH JOURNAL OF CANCER
- Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
- (2010) T Trarbach et al. BRITISH JOURNAL OF CANCER
- Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75
- (2010) M C Ryan et al. BRITISH JOURNAL OF CANCER
- Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ
- (2010) Juan Dubrot et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Glucocorticoid-Induced TNFR-Related (GITR) Protein and Its Ligand in Antitumor Immunity: Functional Role and Therapeutic Modulation
- (2010) Theresa Placke et al. Clinical & Developmental Immunology
- A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies
- (2010) D. R. Camidge et al. CLINICAL CANCER RESEARCH
- Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms
- (2010) P. A. Culp et al. CLINICAL CANCER RESEARCH
- Characteristics and Development of TRX518, an Aglycosyl Humanized Monoclonal Antibody (Mab) Agonist of huGITR
- (2010) Joe Ponte et al. CLINICAL IMMUNOLOGY
- TNFSF9 expression in primary biliary cirrhosis and its clinical significance
- (2010) Rong Xia et al. CYTOKINE
- A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma
- (2010) M. Hussein et al. HAEMATOLOGICA
- Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serum
- (2010) F. Chowdhury et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Polymorphic Variants of LIGHT (TNF Superfamily-14) Alter Receptor Avidity and Bioavailability
- (2010) T. C. Cheung et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10-Producing Regulatory B Cells
- (2010) M. Yang et al. JOURNAL OF IMMUNOLOGY
- CD137-Mediated Pathogenesis from Chronic Hepatitis to Hepatocellular Carcinoma in Hepatitis B Virus-Transgenic Mice
- (2010) J. Wang et al. JOURNAL OF IMMUNOLOGY
- Tumor Necrosis Factor Receptor/Tumor Necrosis Factor Family Members in Antiviral CD8 T-Cell Immunity
- (2010) Shahram Salek-Ardakani et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia
- (2010) Richard R. Furman et al. LEUKEMIA & LYMPHOMA
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
- (2010) Massimo Ammirante et al. NATURE
- Tumor necrosis factor blockade and the risk of viral infection
- (2010) Seo Young Kim et al. Nature Reviews Rheumatology
- APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo
- (2010) G. Eisele et al. NEURO-ONCOLOGY
- Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
- (2010) Nancy E. Lane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis
- (2010) John T. Sharp et al. ARTHRITIS CARE & RESEARCH
- Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients
- (2010) A. Deodhar et al. ARTHRITIS CARE & RESEARCH
- Atacicept: targeting B cells in multiple sclerosis
- (2010) Hans-Peter Hartung et al. Therapeutic Advances in Neurological Disorders
- A Human Anti-CD40 Monoclonal Antibody, 4D11, for Kidney Transplantation in Cynomolgus Monkeys: Induction and Maintenance Therapy
- (2009) T. Aoyagi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
- (2009) A. Di Stasi et al. BLOOD
- Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study
- (2009) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma
- (2009) Andres Forero-Torres et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
- (2009) Johannes Haybaeck et al. CANCER CELL
- TNF superfamily: Costimulation and clinical applications
- (2009) Dass S. Vinay et al. CELL BIOLOGY INTERNATIONAL
- Combining Radiotherapy with APO010 in Cancer Treatment
- (2009) I. Verbrugge et al. CLINICAL CANCER RESEARCH
- A Phase II Study of SGN-30 in Cutaneous Anaplastic Large Cell Lymphoma and Related Lymphoproliferative Disorders
- (2009) M. Duvic et al. CLINICAL CANCER RESEARCH
- Origins and functional basis of regulatory CD11c+CD8+T cells
- (2009) Dass S. Vinay et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy
- (2009) Norma Lynn Fox et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers
- (2009) Sven Schüngel et al. HEPATOLOGY
- The Many Roles of FAS Receptor Signaling in the Immune System
- (2009) Andreas Strasser et al. IMMUNITY
- Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology
- (2009) Martijn A. Nolte et al. IMMUNOLOGICAL REVIEWS
- Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease
- (2009) Eugene Y Chiang et al. NATURE MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
- (2009) Daniel E. Furst SEMINARS IN ARTHRITIS AND RHEUMATISM
- CD40 and autoimmunity: The dark side of a great activator
- (2009) Anna L. Peters et al. SEMINARS IN IMMUNOLOGY
- A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity
- (2009) Rich-Henry Schabowsky et al. VACCINE
- OX40 (CD134) expression in sentinel lymph nodes correlates with prognostic features of primary melanomas
- (2008) MaryClare Sarff et al. AMERICAN JOURNAL OF SURGERY
- The effect of anti-CD40 ligand in immune thrombocytopenic purpura
- (2008) Vivek L. Patel et al. BRITISH JOURNAL OF HAEMATOLOGY
- The BLyS Family: Toward a Molecular Understanding of B Cell Homeostasis
- (2008) John F. Treml et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- CD137 Is Expressed in Human Atherosclerosis and Promotes Development of Plaque Inflammation in Hypercholesterolemic Mice
- (2008) Peder S. Olofsson et al. CIRCULATION
- Phase I Clinical Study of Atacicept in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
- (2008) S. M. Ansell et al. CLINICAL CANCER RESEARCH
- Preclinical Characterization of SGN-70, a Humanized Antibody Directed against CD70
- (2008) J. A. McEarchern et al. CLINICAL CANCER RESEARCH
- Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis
- (2008) Giorgos Bamias et al. CLINICAL IMMUNOLOGY
- Targeting tumors with LIGHT to generate metastasis-clearing immunity
- (2008) Ping Yu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response
- (2008) Yanping Xiao et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Comparative Analysis of the Expression Patterns of Various TNFSF/TNFRSF in Atherosclerotic Plaques
- (2008) Won-Jung Kim et al. IMMUNOLOGICAL INVESTIGATIONS
- Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease
- (2008) Jeffrey L. Browning IMMUNOLOGICAL REVIEWS
- Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetics and Biological Activity of Atacicept in Patients With Rheumatoid Arthritis
- (2008) Ivan Nestorov et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical association of serum CD137 (4-1BB) levels in patients with systemic sclerosis
- (2008) Yasuhito Hamaguchi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
- (2008) Jeffrey A. Winkles NATURE REVIEWS DRUG DISCOVERY
- Reverse signaling initiated from GITRL induces NF-κB activation through ERK in the inflammatory activation of macrophages
- (2007) Eun Mi Bae et al. MOLECULAR IMMUNOLOGY
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now